Deep phenotyping of post-infectious myalgic encephalomyelitis/chronic fatigue syndrome

Brian Walitt(National Institute of Neurological Disorders and Stroke), Komudi Singh(National Heart Lung and Blood Institute), Samuel R. LaMunion(National Institute of Diabetes and Digestive and Kidney Diseases), Mark Hallett(National Institute of Neurological Disorders and Stroke), Steve Jacobson(National Institute of Neurological Disorders and Stroke), Kong Y. Chen(National Institute of Diabetes and Digestive and Kidney Diseases), Yoshimi Enose‐Akahata(National Institute of Neurological Disorders and Stroke), Richard Apps, Jennifer J. Barb(National Institutes of Health Clinical Center), Patrick Bédard(National Institute of Neurological Disorders and Stroke), Robert J. Brychta(National Institute of Diabetes and Digestive and Kidney Diseases), Ashura Buckley(National Institute of Mental Health), Peter D. Burbelo(National Institute of Dental and Craniofacial Research), Brice Calco(National Institute of Neurological Disorders and Stroke), Brianna Cathay(Texas A&M University), Li Chen(Affiliated Hospital of North Sichuan Medical College), Snigdha Chigurupati(George Washington University Hospital), Jinguo Chen, Foo Cheung, Lisa M. K. Chin(National Institutes of Health Clinical Center), Benjamin W. Coleman(Allegheny General Hospital), Amber B. Courville(National Institute of Diabetes and Digestive and Kidney Diseases), Madeleine S. Deming(National Institutes of Health Clinical Center), Bart Drinkard(National Institutes of Health Clinical Center), Li Feng(National Institute on Drug Abuse), Luigi Ferrucci(National Institute on Aging), Scott A. Gabel(National Institute of Environmental Health Sciences), Angelique Gavin(National Institute of Neurological Disorders and Stroke), David S. Goldstein(National Institute of Neurological Disorders and Stroke), Shahin Hassanzadeh(National Heart Lung and Blood Institute), Sean C. Horan(Sidney Kimmel Cancer Center), Silvina G. Horovitz(National Institute of Neurological Disorders and Stroke), Kory R. Johnson(National Institute of Neurological Disorders and Stroke), Anita Jones Govan(National Institute of Neurological Disorders and Stroke), Kristine M. Knutson(National Institute of Neurological Disorders and Stroke), Joy D. Kreskow(National Institute of Nursing Research), Mark Levin(National Heart Lung and Blood Institute), Jonathan J. Lyons(National Institute of Allergy and Infectious Diseases), Nicholas Madian(National Center for Complementary and Integrative Health), Nasir Malik(National Institute of Neurological Disorders and Stroke), Andrew L. Mammen(National Institute of Arthritis and Musculoskeletal and Skin Diseases), John A. McCulloch(National Cancer Institute), Patrick McGurrin(National Institute of Neurological Disorders and Stroke), Joshua D. Milner(Columbia University Irving Medical Center), Ruin Moaddel(National Institute on Aging), Geoffrey A. Mueller(National Institute of Environmental Health Sciences), Amrita Mukherjee, Sandra Muñoz-Braceras(National Institute of Arthritis and Musculoskeletal and Skin Diseases), Gina Norato(National Institute of Neurological Disorders and Stroke), Katherine Pak(National Institute of Arthritis and Musculoskeletal and Skin Diseases), Iago Pinal‐Fernandez(National Institute of Arthritis and Musculoskeletal and Skin Diseases), Traian Popa(National Institute of Neurological Disorders and Stroke), Lauren Reoma(National Institute of Neurological Disorders and Stroke), Michael N. Sack(National Heart Lung and Blood Institute), Farinaz Safavi(National Institute of Neurological Disorders and Stroke), Leorey N. Saligan(National Institute of Nursing Research), Brian A. Sellers, Stephen Sinclair(National Institute of Mental Health), Bryan Smith(National Institute of Neurological Disorders and Stroke), Joseph Snow(National Institute of Mental Health), Stacey Solin(National Institutes of Health Clinical Center), Barbara Stussman(National Center for Complementary and Integrative Health), Giorgio Trinchieri(National Cancer Institute), Sara A. Turner(National Institutes of Health Clinical Center), C. Stephenie Vetter, Felipe Vial(Universidad del Desarrollo), Carlotta Vizioli(National Institute of Neurological Disorders and Stroke), Ashley Williams(Oakland University), Shanna Yang(National Institutes of Health Clinical Center), Avindra Nath(National Institute of Neurological Disorders and Stroke)
Nature Communications
February 21, 2024
Cited by 118Open Access
Full Text

Abstract

Post-infectious myalgic encephalomyelitis/chronic fatigue syndrome (PI-ME/CFS) is a disabling disorder, yet the clinical phenotype is poorly defined, the pathophysiology is unknown, and no disease-modifying treatments are available. We used rigorous criteria to recruit PI-ME/CFS participants with matched controls to conduct deep phenotyping. Among the many physical and cognitive complaints, one defining feature of PI-ME/CFS was an alteration of effort preference, rather than physical or central fatigue, due to dysfunction of integrative brain regions potentially associated with central catechol pathway dysregulation, with consequences on autonomic functioning and physical conditioning. Immune profiling suggested chronic antigenic stimulation with increase in naïve and decrease in switched memory B-cells. Alterations in gene expression profiles of peripheral blood mononuclear cells and metabolic pathways were consistent with cellular phenotypic studies and demonstrated differences according to sex. Together these clinical abnormalities and biomarker differences provide unique insight into the underlying pathophysiology of PI-ME/CFS, which may guide future intervention.


Related Papers